Titlebook: Medical Image Computing and Computer-Assisted Intervention -- MICCAI 2012; 15th International C Nicholas Ayache,Hervé Delingette,Kensaku Mo

Biofeedback

ODIUM

現(xiàn)任者

Conference proceedings 2012on abdominal imaging, computer-assisted interventions and robotics; computer-aided diagnosis and planning; image reconstruction and enhancement; analysis of microscopic and optical images; computer-assisted interventions and robotics; image segmentation; cardiovascular imaging; and brain imaging: structure, function and disease evolution.

共同給與

Conference proceedings 2012d Computer-Assisted Intervention, MICCAI 2012, held in Nice, France, in October 2012. Based on rigorous peer reviews, the program committee carefully selected 252 revised papers from 781 submissions for presentation in three volumes. The first volume includes 91 papers organized in topical sections

CUR

公理

乏味

Robin Wolz,Chengwen Chu,Kazunari Misawa,Kensaku Mori,Daniel Rueckertluable guide to image interpretation, with clear instruction.Although [.18.F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaini

指令

Benoit Diotte,Pascal Fallavollita,Lejing Wang,Simon Weidert,Peter-Helmut Thaller,Ekkehard Euler,Nassluable guide to image interpretation, with clear instruction.Although [.18.F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaini

拋物線

Siyang Zuo,Takeshi Ohdaira,Kenta Kuwana,Yoshihiro Nagao,Satoshi Ieiri,Makoto Hashizume,Takeyoshi Dohluable guide to image interpretation, with clear instruction.Although [.18.F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaini

expire

Benjamín Béjar Haro,Luca Zappella,René Vidalluable guide to image interpretation, with clear instruction.Although [.18.F]fluorodeoxyglucose (FDG) generally shows an excellent performance as a cancer-imaging agent when using PET-CT, there are some settings in which other radiopharmaceuticals offer advantages. Such non-FDG tracers are now gaini